Clinical Trials

The James Cancer Center Columbus, OH

open for enrollment

Randomized Study Adjuvant v Neoadjuvant Mk-3475 Clinically Detectable Stage III-IV High Risk Melanom

Protocol: SWOG-S1801

Full Title

A Phase II Randomized Study of Adjuvant versus Neoadjuvant Mk-3475 (Pembrolizumab) for Clinically Detectable Stage III-IV High Risk Melanoma

Melanoma Skin Cancers